Evidence from single nucleotide polymorphism analyses of ADVANCE study demonstrates EFNB3 as a hypertension risk gene
AuthorTremblay, J; Wang, Y; Raelson, J; Marois-Blanchet, F-C; Wu, Z; Luo, H; Bradley, E; Chalmers, J; Woodward, M; Harrap, S; ...
Source TitleScientific Reports
PublisherNATURE PUBLISHING GROUP
University of Melbourne Author/sHarrap, Stephen
Document TypeJournal Article
CitationsTremblay, J., Wang, Y., Raelson, J., Marois-Blanchet, F. -C., Wu, Z., Luo, H., Bradley, E., Chalmers, J., Woodward, M., Harrap, S., Hamet, P. & Wu, J. (2017). Evidence from single nucleotide polymorphism analyses of ADVANCE study demonstrates EFNB3 as a hypertension risk gene. SCIENTIFIC REPORTS, 7 (1), https://doi.org/10.1038/srep44114.
Access StatusOpen Access
EPH kinases and their ligands, ephrins (EFNs), have vital and diverse biological functions. We recently reported that Efnb3 gene deletion results in hypertension in female but not male mice. These data suggest that EFNB3 regulates blood pressure in a sex- and sex hormone-dependent way. In the present study, we conducted a human genetic study to assess the association of EFNB3 single nucleotide polymorphisms with human hypertension risks, using 3,448 patients with type 2 diabetes from the ADVANCE study (Action in Diabetes and Vascular Disease: Peterax and Diamicron MR Controlled Evaluation). We have observed significant association between 2 SNPs in the 3' untranslated region or within the adjacent region just 3' of the EFNB3 gene with hypertension, corroborating our findings from the mouse model. Thus, our investigation has shown that EFNB3 is a hypertension risk gene in certain individuals.
- Click on "Export Reference in RIS Format" and choose "open with... Endnote".
- Click on "Export Reference in RIS Format". Login to Refworks, go to References => Import References